Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Date - Month Sort ascending Organization
14
Dec 23
Provisional Political Agreement on Landmark Ai Regulation in Europe K&L Gates
14
Dec 23
PTAB’s Decision of a Singular-Only Construction of the Term “The Sample Stream” Reversed Sheppard, Mullin, Richter & Hampton LLP
14
Dec 23
Parody of Iconic Sneaker Isn’t Entitled to Heightened First Amendment Protection McDermott Will & Emery
14
Dec 23
Federal Circuit Vacates District Court’s Claim Construction of the Term “Pipette Guiding Mechanism” Sheppard, Mullin, Richter & Hampton LLP
14
Dec 23
If the Label Is Skinny Enough – No Inducement Under Hatch-Waxman McDermott Will & Emery
14
Dec 23
USPTO to Open Regional Office in Atlanta Womble Bond Dickinson (US) LLP
14
Dec 23
Sound the Alarm: Reasonable Royalty Apportionment Analysis Overlooks “Sleep State” McDermott Will & Emery
14
Dec 23
Second Circuit Hands Vans a Win in First Appellate Decision to Apply Jack Daniel’s Greenberg Traurig, LLP
13
Dec 23
Supercapacitor Patent Row Between CAP-XX and Maxwell Technologies Goes to Court this Week Mintz
13
Dec 23
Aussie Burger Wars Continue: KFC v HFC K&L Gates
13
Dec 23
Federal Circuit Evaluates Impact of the Final Written Decision (FWD) in a Parallel Inter-Partes Review (IPR) on District Court’s decision of Invalidity and Infringement Sheppard, Mullin, Richter & Hampton LLP
13
Dec 23
Influence At Your Own Risk: Navigating Influencer Contracts ArentFox Schiff LLP
13
Dec 23
A Proposed Likeness Law Paves the Way for a New Federal Right of Action Squire Patton Boggs (US) LLP
12
Dec 23
Copyright Office Review Board Denies AI-Human Authorship Claim for Third Time ArentFox Schiff LLP
12
Dec 23
How Artificial Intelligence is Changing the Game of Professional Sports Squire Patton Boggs (US) LLP
11
Dec 23
Startup Advisors: What Sources of Financing are Available to Startups? [VIDEO] Foley & Lardner LLP
11
Dec 23
The March on Pharmaceutical Patents? Sheppard, Mullin, Richter & Hampton LLP
11
Dec 23
Deadline Dexterity: PTAB Has Authority to Issue Decisions After Statutory Deadline Proskauer Rose LLP
10
Dec 23
Second Circuit Finds Art Collective Can’t Use First Amendment to Skate Out of Injunction Sheppard, Mullin, Richter & Hampton LLP
10
Dec 23
Will Supreme Court Consider Whether to Allow an Alternative to In-App Purchasing on the App Store? Sheppard, Mullin, Richter & Hampton LLP
10
Dec 23
Federal Circuit Vacates PTAB’s Decision Based on an Overly Narrow Claim Construction Sheppard, Mullin, Richter & Hampton LLP
10
Dec 23
China Releases Second Batch of Warning Cases in ‘Blue Sky’ Special Rectification Program of the Patent Agent Industry Schwegman, Lundberg & Woessner, P.A.
10
Dec 23
Federal Circuit’s Determination on Whether Fraudulent Conduct in Obtaining Incontestable Status Warrants the Mark’s Cancellation Sheppard, Mullin, Richter & Hampton LLP
10
Dec 23
Cyntec Company, Ltd. v. Chilisin Electronics Corp., Chilisin America Ltd. Nos. 2022-1873, (Fed. Cir. October 16, 2023) Sheppard, Mullin, Richter & Hampton LLP
10
Dec 23
Axonics, Inc. v. Medtronic, Inc. Nos. 2022-1532, 2022-1533, (Fed. Cir. August 7, 2023) Sheppard, Mullin, Richter & Hampton LLP
9
Dec 23
Unpredictability In The Art: Amgen v. Sanofi In View Of “Simultaneous Conception And Reduction To Practice” Womble Bond Dickinson (US) LLP
7
Dec 23
The Art of Teaching Complex Technology in Patent Litigation – Episode 67 [Podcast] IMS Consulting & Expert Services
7
Dec 23
Question of the Week: What Do You Expect the Biggest Impacts of Generative AI (GenAI) to be on M&A in the Next 12-18 Months? Proskauer Rose LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins